# Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia

> **NCT04380376** · PHASE2 · UNKNOWN · sponsor: **Federal State Budgetary Institution, Pulmonology Scientific Research Institute** · enrollment: 60 (estimated)

## Conditions studied

- COVID-19
- Viral Pneumonia

## Interventions

- **DRUG:** Melphalan
- **OTHER:** Standard of care

## Key facts

- **NCT ID:** NCT04380376
- **Lead sponsor:** Federal State Budgetary Institution, Pulmonology Scientific Research Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-30
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380376

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380376, "Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04380376. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*